Purba Basu

434 total citations
23 papers, 181 citations indexed

About

Purba Basu is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Purba Basu has authored 23 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Purba Basu's work include Neurological disorders and treatments (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Genetic Neurodegenerative Diseases (4 papers). Purba Basu is often cited by papers focused on Neurological disorders and treatments (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Genetic Neurodegenerative Diseases (4 papers). Purba Basu collaborates with scholars based in India, United Kingdom and Bangladesh. Purba Basu's co-authors include Hrishikesh Kumar, Supriyo Choudhury, Banashree Mondal, Koustav Chatterjee, Rebecca Banerjee, Shantanu Shubham, Sanjit Dey, Prashanth Lingappa Kukkle, Niraj Kumar and Vinay Goyal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Neuroscience Letters.

In The Last Decade

Purba Basu

20 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Purba Basu India 6 102 50 45 32 28 23 181
Martina Giuntini Italy 9 135 1.3× 22 0.4× 26 0.6× 24 0.8× 19 0.7× 12 229
Murat Gültekin Türkiye 13 124 1.2× 51 1.0× 99 2.2× 44 1.4× 32 1.1× 53 330
James V. Lee United States 4 58 0.6× 24 0.5× 37 0.8× 52 1.6× 52 1.9× 5 202
Antonio Callén Spain 5 68 0.7× 46 0.9× 16 0.4× 23 0.7× 12 0.4× 7 156
Matthew T. Hoerth United States 9 106 1.0× 25 0.5× 27 0.6× 39 1.2× 14 0.5× 20 314
A. Castro Spain 8 194 1.9× 17 0.3× 14 0.3× 54 1.7× 22 0.8× 13 236
M. Gold United States 7 119 1.2× 18 0.4× 10 0.2× 31 1.0× 10 0.4× 21 191
Reinaldo Uribe-San-Martín Chile 10 85 0.8× 16 0.3× 24 0.5× 36 1.1× 11 0.4× 22 292
Nicoleta Carmen Cosma Germany 6 218 2.1× 16 0.3× 52 1.2× 23 0.7× 5 0.2× 12 341
Niall J Crosby United Kingdom 6 151 1.5× 14 0.3× 43 1.0× 91 2.8× 15 0.5× 11 281

Countries citing papers authored by Purba Basu

Since Specialization
Citations

This map shows the geographic impact of Purba Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Purba Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Purba Basu more than expected).

Fields of papers citing papers by Purba Basu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Purba Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Purba Basu. The network helps show where Purba Basu may publish in the future.

Co-authorship network of co-authors of Purba Basu

This figure shows the co-authorship network connecting the top 25 collaborators of Purba Basu. A scholar is included among the top collaborators of Purba Basu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Purba Basu. Purba Basu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garg, Divyani, Vikram V. Holla, Jacky Ganguly, et al.. (2024). Expanding the phenotypic and genotypic spectrum of DYT-TUBB4A with seven patients from India. Parkinsonism & Related Disorders. 124. 107012–107012. 1 indexed citations
2.
Basu, Purba, et al.. (2024). Non-motor symptoms in patients with Spinocerebellar ataxia type 12. Frontiers in Neurology. 15. 1464149–1464149.
3.
Mondal, Banashree, Supriyo Choudhury, Rebecca Banerjee, et al.. (2024). Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease. Frontiers in Aging Neuroscience. 15. 1331575–1331575. 9 indexed citations
4.
Kumar, Hrishikesh, Supriyo Choudhury, Rebecca Banerjee, et al.. (2023). Dietary and environmental risk factors in Parkinson's and Alzheimer's disease: A semi-quantitative pilot study. Annals of Indian Academy of Neurology. 26(2). 174–174. 1 indexed citations
5.
Chatterjee, Koustav, et al.. (2023). Characterizing gait and exploring neuro-morphometry in patients with PSP-Richardson's syndrome and vascular parkinsonism. Parkinsonism & Related Disorders. 113. 105483–105483. 4 indexed citations
6.
Ganguly, Jacky, et al.. (2023). Hypomyelinating leukodystrophy and movement disorders. SHILAP Revista de lepidopterología. 6(2). 58–71. 1 indexed citations
7.
Ganguly, Jacky, et al.. (2022). Think of SCA45 in Late‐Onset Familial Ataxias: The First Report from the Indian Subcontinent with a Novel Variant. Movement Disorders Clinical Practice. 9(8). 1140–1143. 1 indexed citations
8.
Chatterjee, Koustav, et al.. (2022). Is peripheral alpha synuclein a marker for gait velocity in Parkinson’s disease?. Neuroscience Letters. 786. 136819–136819. 4 indexed citations
9.
Choudhury, Supriyo, Nazrul Islam, Purba Basu, et al.. (2021). Comparing Stop Signal Reaction Times in Alzheimer’s and Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49(5). 662–671. 5 indexed citations
10.
Choudhury, Supriyo, et al.. (2021). A longitudinal quantitative analysis of gait in patients with SCA-12. Clinical Parkinsonism & Related Disorders. 5. 100102–100102. 3 indexed citations
11.
Chatterjee, Koustav, et al.. (2021). Semantic Fluency Predicts Gait Velocity in PSP. Annals of Indian Academy of Neurology. 24(6). 896–900. 6 indexed citations
12.
Chatterjee, Koustav, et al.. (2021). Clinical Significance of Applause Sign in Patients with Progressive Supranuclear Palsy. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49(6). 809–812. 1 indexed citations
13.
Mondal, Banashree, et al.. (2021). Effect of Mask on Doctor–Patient Relationship during COVID-19. Annals of Indian Academy of Neurology. 25(2). 270–271. 1 indexed citations
14.
Choudhury, Supriyo, et al.. (2021). Asymmetry of Tremor in Spinocerebellar Ataxia 12‐ Exception or Rule?. Movement Disorders Clinical Practice. 8(5). 809–811. 5 indexed citations
15.
Kumar, Niraj, Ravi Gupta, Hrishikesh Kumar, et al.. (2020). Impact of home confinement during COVID-19 pandemic on sleep parameters in Parkinson's disease. Sleep Medicine. 77. 15–22. 31 indexed citations
16.
Mondal, Banashree, Rebecca Banerjee, Supriyo Choudhury, et al.. (2020). Interplay of cytokines and nerve-growth factor in patients with Parkinson's Disease: A study in Eastern Indian population. Parkinsonism & Related Disorders. 79. e84–e84. 1 indexed citations
17.
Mondal, Banashree, Supriyo Choudhury, Rebecca Banerjee, et al.. (2020). Long-term effect of non-invasive Vagus Nerve in patients with Parkinson's disease: A randomized double blind controlled study. Parkinsonism & Related Disorders. 79. e61–e61. 1 indexed citations
18.
Chatterjee, Koustav, Rebecca Banerjee, Supriyo Choudhury, et al.. (2019). Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study. Journal of Neuroimmunology. 338. 577089–577089. 90 indexed citations
19.
Basu, Purba, et al.. (2011). PL-010 Turmeric enema: a novel therapy for C. difficile colitis (CDAD): A randomized, double blinded, placebo controlled prospective clinical trial. International Journal of Infectious Diseases. 15. S39–S39. 1 indexed citations
20.
Gupta, Chhavi, J. B. Chatterjea, & Purba Basu. (1953). Vitamin B12 in Macrocytic Anæmia in Pregnancy.. PubMed. 88(2). 75–108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Giuntini Breakdown of academic impact, for papers by Murat Gültekin Breakdown of academic impact, for papers by James V. Lee Breakdown of academic impact, for papers by Antonio Callén Breakdown of academic impact, for papers by Matthew T. Hoerth Breakdown of academic impact, for papers by A. Castro Breakdown of academic impact, for papers by M. Gold Breakdown of academic impact, for papers by Reinaldo Uribe-San-Martín Breakdown of academic impact, for papers by Nicoleta Carmen Cosma Breakdown of academic impact, for papers by Niall J Crosby
Rankless by CCL
2026